Moderna, Inc. MRNA
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$229.69$245.37
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.83% | -17.54% | 309.30% | -31.13% | -46.54% |
| Total Other Revenue | -6.98% | 82.14% | 68.18% | 14.29% | 2.38% |
| Total Revenue | 29.23% | 2.11% | 260.19% | -29.81% | -45.44% |
| Cost of Revenue | -11.21% | -9.89% | -23.26% | -34.07% | -38.95% |
| Gross Profit | 5,125.00% | 12.41% | 59.79% | 38.66% | -96.21% |
| SG&A Expenses | 5.22% | -6.09% | -18.40% | -12.25% | -4.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.76% | -9.06% | -22.37% | -30.61% | -33.95% |
| Operating Income | 152.31% | 10.80% | 51.43% | 31.22% | -271.43% |
| Income Before Tax | 191.44% | 6.23% | -38.38% | 32.52% | -990.48% |
| Income Tax Expenses | -30.77% | 114.29% | 28.57% | 142.19% | 62.50% |
| Earnings from Continuing Operations | 181.00% | 5.21% | -38.31% | 26.25% | -1,638.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 181.00% | 5.21% | -38.31% | 26.25% | -1,638.46% |
| EBIT | 152.31% | 10.80% | 51.43% | 31.22% | -271.43% |
| EBITDA | 198.08% | 12.24% | 55.39% | 33.39% | -1,055.56% |
| EPS Basic | 178.78% | 7.60% | -35.16% | 27.57% | -1,617.16% |
| Normalized Basic EPS | 190.62% | 9.31% | 53.54% | 33.38% | -728.54% |
| EPS Diluted | 173.93% | 7.60% | -35.16% | 27.65% | -1,809.33% |
| Normalized Diluted EPS | 184.51% | 9.31% | 53.54% | 33.38% | -751.28% |
| Average Basic Shares Outstanding | 2.82% | 2.58% | 2.33% | 1.82% | 1.30% |
| Average Diluted Shares Outstanding | 10.26% | 2.58% | 2.33% | 1.82% | -2.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |